Elevated hepatic lipid and interferon stimulated gene expression in HCV GT3 patients relative to non-alcoholic steatohepatitis-Reference-Cited by-同舟云学术

Elevated hepatic lipid and interferon stimulated gene expression in HCV GT3 patients relative to non-alcoholic steatohepatitis

Published:2016-05-18 Issue:6 Volume:10 Page:937-946
ISSN:1936-0533
Container-title:Hepatology International
language:en
Short-container-title:Hepatol Int

Author:

Shrivastava Shikha,Meissner Eric G.,Funk Emily,Poonia Seerat,Shokeen Virender,Thakur Arun,Poonia Bhawna,Sarin Shiv Kumar,Trehanpati Nirupma,Kottilil Shyamasundaran

Funder

National Institute of Allergy and Infectious Diseases (NIH), Bethesda, United States

Institute of Liver and biliary Sciences, New Delhi, India

Publisher

Springer Science and Business Media LLC

Subject

Hepatology

Link

http://link.springer.com/content/pdf/10.1007/s12072-016-9733-6.pdf

Reference24 articles.

1. MohdHanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age specific antibody to HCV seroprevalence. Hepatology 2013;57:1333–1342

2. Ekstedt M, Franzen LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006;44:865–873

3. Teli MR, James OF, Burt AD, Bennett MK, Day CP. The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology 1995;22:1714–1719

4. Lomonaco R, Chen J, Cusi K. An endocrine perspective of nonalcoholic fatty liver disease (NAFLD). Ther Adv Endocrinol Metabol 2011;2:211–225

5. Lonardo A, Loria P, Adinolfi LE, Carulli N, Ruggiero G. Hepatitis C and steatosis: a reappraisal. J Viral Hepat 2006;13(2):73–80

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive analysis of shared risk genes and immunity-metabolisms between non-alcoholic fatty liver disease and atherosclerosis via bulk and single-cell transcriptome analyses;Heliyon;2024-08

2. Shared biomarkers and immune cell infiltration signatures in ulcerative colitis and nonalcoholic steatohepatitis;Scientific Reports;2023-10-28

3. The Role of JAK/STAT Pathway in Fibrotic Diseases: Molecular and Cellular Mechanisms;Biomolecules;2023-01-06

4. Differences of core genes in liver fibrosis and hepatocellular carcinoma: Evidence from integrated bioinformatics and immunohistochemical analysis;World Journal of Gastrointestinal Oncology;2022-07-15

5. The Role of Interferon Regulatory Factors in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis;Gastroenterology Insights;2022-04-26